New Stomach-Suturing device could help obese asians lose weight without surgery

NCT ID NCT07276815

Not yet recruiting Disease control Sponsor: Boston Scientific Corporation Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 30, 2026 · Updated 4 times

Summary

This study tests a device called OverStitch NXT, which uses sutures to reduce stomach size through an endoscope (a tube down the throat), avoiding traditional surgery. It involves 136 obese Asian adults with a BMI of 27.5 or higher, some with diabetes or other obesity-related conditions. The goal is to see if the procedure is safe and helps patients lose at least 5% of their body weight after 12 months.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: OverStitch NXT Endoscopic Suture System (a device that places sutures in the stomach to reduce its size)
What this could lead to: If successful, this could provide a less invasive, non-surgical option for significant weight loss in obese individuals, potentially improving health outcomes.
What could go wrong: This is an early-stage study with only 136 participants, so results may not apply to everyone. The procedure carries risks like any endoscopic intervention, and long-term weight loss maintenance is uncertain.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

obesity disorder Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

WEIGHT LOSS

More trials for these conditions

Other studies related to the condition(s) this trial covers.